Science AI Journal

Microbial Drug Resistance

ISSN 1076-6294 · Mary Ann Liebert, Inc. · United States · active 1975–2026

Metrics

Scimago quartile
Q2
Cites per paper (2y)
1.3
SJR
0.605
h-index
89

“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.

Indexing & access

ScopusWeb of SciencePubMed

Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.

Scope

antibioticresistancebacteriamolecularmedicineantimicrobialstaphylococcusinfectiousdiseasesbacterialbiofilmsquorum

Frequently asked

Is Microbial Drug Resistance a predatory journal?

Our screening does not flag Microbial Drug Resistance. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.

Is Microbial Drug Resistance indexed in Scopus or Web of Science?

Per our venue index, Microbial Drug Resistance appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.

What is Microbial Drug Resistance's impact?

Papers in Microbial Drug Resistance are cited about 1.3 times each within two years of publication, and Scimago places it in Q2, with an h-index of 89. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.

Is Microbial Drug Resistance open access?

We hold no reliable open-access classification for Microbial Drug Resistance. Check the journal's own site for its access model and any article processing charge.

Similar venues

Command palette

Jump anywhere, run any action.